Anti-Amyloid Class Labeling Could See Changes With Lilly’s Donanemab Approval

 
• By Sue Sutter
Alzheimers imaging
ARIA symptoms in Alzheimer's patients may mimic the signs of ischemic stroke. • Source: Shutterstock

More from US FDA Performance Tracker

More from Regulatory Trackers